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Available online 23 July 2011Tyrosine kinase 2 (Tyk2) is an integral part of the Janus kinase-signal transducer and
activator of transcription (JAK-STAT) pathway which relays intracellular signals of various
cytokines. Tyk2 crucially contributes to host defense mechanisms against microbial
pathogens and to tumor surveillance but also facilitates immune pathologies. Here we
investigated the impact of Tyk2 on the macrophage proteome using the synthetic double-
stranded RNA analog polyinosinic acid-polycytidylic acid (poly(I:C)) as a mimicry of viral
infections. By means of 2D-DIGE in connection with PMF obtained by MALDI-MS and
sequence tag determination by MS/MS we unambiguously identified eighteen protein spots
corresponding to sixteen distinct proteins that are regulated by poly(I:C) and differentially
expressed between wildtype (WT) and Tyk2-deficient macrophages. The majority of these
proteins are functionally assigned to cellular immune responses and to metabolism. We
show for selected metabolic enzymes, i.e. triosephosphate isomerase (TIM), ATP-citrate
synthase (ACLY) and long-chain-fatty-acid-CoA ligase 4 (ACSL4), that Tyk2 affects protein
expression transcriptionally and post-transcriptionally. We furthermore confirm the
involvement of Tyk2 in the regulation of lipid and carbohydrate metabolism at the level
of metabolites. Taken together, our results provide new evidence for important functions of
Tyk2 at the molecular interface between innate immunity and cellular metabolism.
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2867J O U R N A L O F P R O T E O M I C S 7 4 ( 2 0 1 1 ) 2 8 6 6 – 2 8 8 01. IntroductionProtein kinases are involved in the regulation of a large number
of cellular processes and dysregulated kinase activity is a
frequent cause of diseases. Tyrosinekinase 2 (Tyk2) is amember
of the Janus kinase (JAK) family of intracellular non-receptor
tyrosine kinases, which are an integral part of the JAK-STAT
(JAK-signal transducer and activator of transcription) pathway
[1,2]. Tyk2 was originally identified in a genetic screen as a
crucial component for type I interferon (IFNα/β) signaling in
human cell lines [3]. In addition, Tyk2 has a role in signal
transduction via a number of other cytokines and some growth
factors [4]. We have shown that mice lacking Tyk2 display
strongly increased susceptibility to infection with viruses, e.g.
lymphocytic choriomeningitis virus (LCMV), vaccinia virus (VV)
[5], andmurinecytomegalovirus (MCMV) [6]. Consistently,Tyk2-
deficient macrophages fail to control MCMV replication in vitro
[6]. To further study the contribution of Tyk2 to macrophage
activity we used synthetic polyinosinic acid-polycytidylic acid
(poly(I:C)) to mimic the presence of double-stranded RNA
(dsRNA), a known (by-)product of virus replication. Poly(I:C) is
recognized by the pattern recognition receptors (PRRs) Toll-like
receptor 3 (TLR3) and by retinoic-acid-inducible gene I (RIG-I)-
like receptors (RLRs) [7,8]. Upon ligand binding several distinct
intracellular pathways convey the signals from these receptors
and result in the activation of a common set of transcription
factors. These include NFκB, which is required for the induction
of pro-inflammatory genes (e.g. interleukin-1β and tumor
necrosis factor α), and members of the IFN-regulatory factor
(IRF) family, which induce transcriptional activation of IFNα/β
genes [7,8]. Followingsecretionandbindingof IFNα/β to the type I
IFN receptor, which is composed of the two subunits IFNAR1 and
IFNAR2, Tyk2 and Jak1 are activated. They auto- and/or trans-
phosphorylate and subsequently phosphorylate mainly Stat1
and Stat2 heterodimers. The phosphorylated heterodimers then
translocate to the nucleus and, in combinationwith IRF9, induce
expression of a large set of IFNα/β-responsive genes [1,9]. The
interplay between PRR- and IFNα/β-induced pathways and the
contribution of additionally activated signaling cascades de-
termines the complex biological responses to poly(I:C). Al-
though different pathogen-associated patterns, like
lipopolysaccharide (LPS) and dsRNA, induce similar and over-
lapping signaling cascades [10], cellular responses can be fairly
different [11].
In a previous study, we used a proteomic approach to
investigate the molecular role of Tyk2 in macrophages in
response to LPS, a structural membrane component of Gram-
negative bacteria recognized by TLR4 [12]. The absence of Tyk2
showed complex consequences on the macrophage proteome
and implied regulatory roles of Tyk2 at the mRNA and post-
transcriptional level before and after treatment with LPS.
In thecurrentwork,weperformedaproteomeanalysisofTyk2-
deficient and wildtype (WT) primary murine macrophages to
identify novelmolecular functions of Tyk2 in response to poly(I:C).
Consistent with our proteomic study using LPS, we show that
Tyk2 is also essential for transcriptional and post-transcrip-
tional responses to poly(I:C).More importantly, our data suggest
novel roles of Tyk2 in the poly(I:C)-mediated regulation of
cellular lipid and carbohydrate metabolism.2. Material and methods
2.1. Materials
All chemicals were of analytical grade or of higher purity
unless stated otherwise. Poly(I:C) (Amersham Biosciences,
Piscataway, NJ, USA) was annealed prior to use to ensure a
high yield of double-stranded configuration. Purified (≥90% by
SDS-PAGE) recombinant murine IFNβ (Calbiochem, San Diego,
CA, USA) was diluted in PBS containing 0.1% BSA.
2.2. Animals, cells and cell lysates
Tyk2-deficient (Tyk2−/−) [5] and IFNAR1-deficient (IFNAR1−/−)
[13]mice have been previously described andwere on a C57BL/6
background (B6.129P2-Tyk2tm1 and B6.129P2-IFNAR1tm1).
C57BL/6 wildtype (WT) mice were purchased from Charles
River Laboratories (Sulzfeld, Germany). Mice were kept under
specified pathogen-free (SPF) conditions andwere sex- and age-
matched (8–12 weeks) for each experiment. Bone marrow-
derived macrophages (BMM) were isolated and grown as
described previously [14]. Following cultivation for 6–7 days,
cellswere incubatedwith 50 μg/mlpoly(I:C) or 500 units/ml IFNβ
for the times indicated. If not stated otherwise, whole cell
lysates were prepared as previously described [12] and used for
2D-DIGE and Western blot analysis. Alternatively, RIPA buffer
(20 mMTris–HClpH7.4, 150mMNaCl, 1%Triton-X-100, 0.5%Na-
deoxycholate; 0.1% SDS and protease inhibitors as described
[12]) was used. Protein concentration was measured by the
Coomassie G-250 (dye reagent, Bio-Rad laboratories, Hercules,
CA, USA) protein binding assay [15].
2.3. 2D-DIGE and statistical analysis
2D-DIGE experiments were designed to comprise three
biological replicates per genotype (WT vs. Tyk2−/− BMM) and
treatment (with or without poly(I:C) for 18 h). DIGE labeling,
2-DE separation and evaluation were performed as previously
described [12]. Briefly, samples were minimally labeled with
CyDye DIGE™ fluorescent dyes (GE Healthcare Life Sciences,
Munich, Germany). Proteins were separated in the first
dimension on 24 cm IPG Dry strips with linear pH gradients
of pH 4–7 and pH 6–9 using the IPGphor III system (all GE
Healthcare). The second dimension was performed on iso-
cratic SDS-PAGE gels (10%T, 25.5×20.5 cm) according to
Laemmli [16] using an Ettan Dalt Six electrophoresis chamber
(GE Healthcare). Lowmolecular weight (LMW)-SDSmarker (GE
Healthcare) was used as Mr standard. Fluorescence images of
the gels were acquired on a Typhoon 9400 scanner (GE
Healthcare). Image analysis including spot detection, match-
ing, normalization and quantification was performed using
DeCyder software Version 5.02 (GE Healthcare).
Statistical analysis of all spots was based on spot volume
ratios. Differentially regulated spots between genotypes (WT
and Tyk2−/−) were selected according to volume ratio and
Student's t-test. Spot matching and spot quality of proteins of
interest weremanually checked to avoid false positives. As we
are mainly interested in genotype-specific differences be-
tween WT and Tyk2−/− BMM, untreated samples were labeled
3 According to the current amino acid numbering in the
UniProtKB database entries, S454 corresponds to S455 in both
human and mouse ACLY (S454 in the rat homolog); this is not
indicated in the antibody datasheet and therefore mentioned
here.
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Differentially regulated spots between WT and Tyk2−/− were
crosschecked for dye labeling bias based on reverse labeling
experiments (untreated/Cy5, treated/Cy3). A pool of equal
amounts of protein from all samples was used as internal
standard and labeled with Cy2.
2.4. Protein identification by MALDI-MS
Protein spots were detected by acidic silver nitrate staining as
previously described using a mass spectrometry (MS)-compat-
ible protocol [17], manually excised and submitted to MS
analysis. In some cases semipreparative 2-DE gels (150 μg
protein load) were used to recover sufficient material for MS
analysis. Spot destaining, in-gel tryptic digestion and sample
preparationusingZipTipμ-C18 (Millipore, Billerica,MA,USA)were
performed as described previously [12]. Peptide mass finger-
printing (PMF) and seamless post source decay (PSD) fragment
ion analysis experiments were performed on a MALDI-reflec-
tron instrument (AXIMA-CFRplus, Shimadzu Biotech Kratos
Analytical, Manchester, UK) equipped with a nitrogen-laser
(λ=337 nm). Dried droplet and thin layer sample preparation
techniques were applied using α-cyano-4-hydroxycinnamic
acid (Sigma-Aldrich, St. Louis, MO, USA) as matrix [18]. Mono-
isotopic valuesof thematrix cluster trimerat [3M+H]+m/z568.15
and autolytic tryptic products at [M+H]+m/z 805.41, [M+H]+m/z
1153.57 and [M+H]+m/z 2163.05 were used for internal calibra-
tion. Autolytic tryptic product ions, matrix cluster ions [19],
keratin and gel blank artifacts [20] were sorted out from the
obtained PMF mass spectra. The resulting monoisotopic list of
m/z values was submitted to search engines MASCOT [21],
revision 2.3, and ProFound [22] searching the databases
UniProtKB/Swiss-Prot (Release 2011_03 of 08-Mar-11) and NCBI
(RefSeq Release 46 of 08-Mar-11) restricting to Mus musculus
taxonomy. Search parameters were set for mass accuracy:
<50 ppm, fixed modification: carbamidomethylation, variable
modifications: methionine oxidation and acetylation at the
protein N-terminal end, and missed cleavages: one. Based on
the measured PMF at least two peptides were selected for PSD
experiments. Search parameters based on these experiments
were identical to PMF experiments, except for precursor ion
mass accuracy (<100 ppm) and product ion tolerance (+/−
1.0 Da). A more stringent search parameter (Da instead of
ppm) was chosen for peptide fragmentation to reduce false
positive results. A protein was considered as identified, if the
scores of database searches clearly exceeded the algorithm's
significance threshold (p<0.05) for PMF data and for sequence
tag ion analyses of at least one peptide.
2.5. RNA isolation, reverse transcription (RT) and
quantitative PCR (qPCR)
Total RNA was isolated from 106 cells using TRIzol (Invitrogen
Life Technologies, Lofer, Austria). RNA (1 μg/20 μl reaction
volume) was reverse transcribed using iScript cDNA synthesis
kit (Bio-Rad, Vienna, Austria). Ubiquitin-conjugating enzyme
E2 D2 (Ube2d2) was used as endogenous control as described
previously [6]. qPCR assays for Tgtp (transcript NM_011579),
Tim/TpiI (transcript NM_009415), Acsl4 (transcript NM_
001033600) and Acly (transcript NM_134037) were carried outwith EvaGreen. The reaction mix contained 2 μl cDNA, 0.3 μM
of each primer, 2.5 mMMgCl2, 0.2 mM each dNTPs, 1× Hotfire B
Puffer, 0.2×EvaGreen (Biotium, Hayward, CA, USA), 1 U Hotfire
Polymerase (Solis BioDyne, Tartu, Estonia) in a final volume of
25 μl. For Tgtp assays 5% DMSOwas added to the reactionmix.
PCR conditions: initial denaturation at 95 °C for 15 min
followed by 45 cycles 95 °C 20 s and 63 °C 40 s. Following
primers were used:
Tgtp (exons 1 and 2, amplicon length 72 bp): 213.fwd-
TTGCCACCAGATCAAGGTCA; 284.rev-TCAAAGCTGGAGGCCC
AAG;
Acly (exons 18 and 19, amplicon length 132 bp): 2206.fwd-
GCGCTACCAGGACACTCCA, 2337.rev-CCGATACACCAGCAGA
CCACT;
Acsl4 (exons 9 and 10, amplicon length 145 bp): 1274.fwd-
ACTTATGGCCGCTGTTCCG, 1419.rev-GGGCGTCATAGCCTTTC
TTG;
Tim/TpiI (exons 6 and 7, amplicon length 92 bp): 860.fwd-
GGGATGGCTGAAATCCAATG, 952.rev-AGCTCTTTGCAGGTT
GCTCC.
Quantitative PCR (qPCR) was performed on a realplex
mastercycler (Eppendorf, Vienna, Austria). Samples (1:4 to
1:6 diluted cDNAs) were amplified in duplicates including a
standard curve and samples without reverse transcriptase
(RT−) were included. Specificity of EvaGreen signals was
controlled with melting curve and agarose gel analyses.
qPCR data were analyzed using realplex (Eppendorf, Vienna,
Austria) software and the standard curvemethodwas used for
the calculation of relative expression levels [23,24]. Statistical
analysis was done with the software SPSS 17.0 (Mac OS-X,
Chicago, IL, USA). Data were log transformed for approximate
normality and analyzed with a linear model (ANOVA) with
genotype, treatment and interaction as factors. The experi-
ment was treated as random factor. A design matrix of zeros
and ones was used to obtain contrasts between genotypes
within a treatment and between treatments for each geno-
type. Appropriate contrasts were calculated (using SPSS) and
resulting p-values are reported. Results are shown as means
±standard error (SE).
2.6. Western blot analysis
Western blots were performed on small-sized SDS-PAGE gels
as described previously [6]. PageRuler prestained protein
ladder (Fermentas, St. Leon-Rot, Germany) was used as a Mr
standard. The following antibodies were used: goat anti-TGTP
(A-20), goat anti-ACSL4 (N-18), and rabbit anti-TIM (N-21)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit anti-
ACLY and anti-phospho-S454 ACLY3 (Cell Signalling, Danvers,
MA, USA); rabbit anti-phospho-T447/S541 ACLY (Epitomics,
Burlingame, CA); mouse anti-extracellular signal regulated
kinase (pan-ERK: p42, p44, p56 and p85) (BD Biosciences
Transduction Laboratories, Lexington, KY, USA); peroxidase-
coupled donkey anti-goat IgG (Jackson ImmunoResearch
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Fig. 1 – Representative silver stained 2-DE protein patterns of
macrophages. Analytical gels visualized by MS-compatible
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HRP F(ab)'2 fragment; sheep anti-mouse IgG-HRP F(ab)'2
fragment; ECL Western Blotting Detection reagents (all GE
Healthcare Life Sciences, Munich, Germany).
2.7. Metabolite analysis: lactate, cholesterol and
triacylglycerol
Supernatants from BMM were collected for extracellular
lactate measurements using a kit from Greiner Diagnostics
(Bahlingen, Germany) following the manufacturer's instruc-
tions. Briefly, 10 μl of supernatant were incubated with 1 ml of
lactate reagent at room temperature for 5 min and the
absorbance was measured at 500 nm.
Lipidswere extracted fromBMM for total cholesterol (TC) and
triacylglycerol (TAG) quantitative analysis. BMM were washed
three times with PBS and incubated with hexane/isopropanol
(60/40, v/v) for 1 h at 4 °C with gentle mixing. Lipid extracts were
transferred to sample vials and evaporated to dryness in a
vacuum centrifuge. The residue was dissolved in chloroform/
methanol (66/33, v/v) and aliquots were taken for TC and TAG
analysis. For TAG quantifications 0.3% Triton X-100 was added
for complete solubilization. Samples were vacuum dried before
determining cellular TC (Greiner Diagnostics, Bahlingen, Germa-
ny) and TAG (Diagnostic Systems, Holzheim, Germany) concen-
trations by enzymatic assays following the manufacturer's
instructions. For total protein content determination (Coomassie
G-250 protein binding assay [15]) 0.3 M NaOH was added to the
cell culture plates after lipid extraction and incubated for 2 h at
room temperature. Cell culture plates were kept at −20 °C
overnight and for 4 h at room temperature before the protein
assay was performed. Data of metabolite (lactate, TC and TAG)
measurementswerenormalized to cellular total protein content.
Statistical evaluationwas performed using the software package
SPSS version 14.0 (SPSS, Chicago, IL, USA). ANOVA and linear
regression were used for statistical analysis as described in
Section 2.5.silver stain. Whole cell extracts (75 μg per gel) were
separated on pH range (A) 4–7 (sample: WT 18 h poly(I:C)
treatment) and (B) 6–9 (sample mix: WT untreated, WT 18 h
poly(I:C) and internal standard). Numbered spots indicate
proteins which have been identified by PMF and sequence
tags applying MALDI-MS (see Table 2 for details).3. Results
3.1. Statistical evaluation of protein spot expression
patterns obtained from 2D-DIGE analysis
Differences in protein patterns in whole cell lysates were
compared between WT and Tyk2−/− bone marrow-derived
macrophages (BMM) with andwithout poly(I:C) treatment. 2D-
DIGE was used at two different pH gradients (pH 4–7 and pH
6–9) to cover a broad pH range and representative 2-DE protein
patterns are shown in Fig.1. A total number of six analytical
gels per pH range was analyzed comprising three biological
replicates per genotype and treatment. Only protein spots
whichwere present in all imageswere included in further data
analysis (Table 1; pH 4–7: 505 spots and pH 6–9: 490 spots).
Experimental variation was assessed based on spot volume
ratios which resulted in amean SD of ±0.079 and ±0.087 for pH
4–7 and pH 6–9, respectively. On average, spot expression
differences of more than 29% (pH 4–7) and 31% (pH 6–9)
produce significant results (p≤0.05) in 90% of the cases with
our experimental set-up (sample size per group=3). Thesehighly reproducible 2D-DIGE spot patterns from whole cell
lysates of primarymurinemacrophages are in agreementwith
our previous study [12]. The focus of the present analysis was
on the impact of Tyk2 before and/or after poly(I:C) treatment.
For further analysis, we only considered spots that were
differentially regulated between the genotypes and that
showed at least 30% difference in spot intensities. 156 protein
spots were significantly changed (p≤0.05) in Tyk2−/− compared
to WT macrophages (Table 1): 14 spots were up-regulated and
32 down-regulated in the untreated state, 56 spots were up-
regulated and 54 down-regulated after poly(I:C) treatment in
the absence of Tyk2. 17 of these 156 spot volume changeswere
found in more than one state, leaving in summary 139 unique
differentially regulated spots. In conclusion, Tyk2 positively
Table 1 – Numbers of differentially expressed spots and statistical evaluation.
Spot selection pH 4–7 pH 6–9
Total number of spots 1647 2036
Number of spots in all images 505 490
Differentially expressed spots a
Untreated 2 (up), 10 (down) 12 (up), 22 (down)
18 h poly(I:C) 10 (up), 34 (down) 46 (up), 20 (down)
Selected spots for protein identification 9 17
Spots/proteins identified 5 13
Experimental variation
Average SD of normalized data 0.08 0.09
Minimal detectable differences b 1.29 1.31
(up) Up-regulated, (down) down-regulated in Tyk2−/− compared to WT macrophages.
a Minimal 1.3-fold change in Tyk2−/− compared to WT cells, p<0.05.
b Fold change (power 90%, sample size/group=3).
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poly(I:C) treatments.
3.2. Absence of Tyk2 influences mainly the expression level
of proteins functionally assigned to immune response or
metabolism
Among the spots showing expression differences, 26 were
selected for protein identification based on previously de-
scribed selection criteria, i.e. spot quality and quantity, spot
traceability on silver stained gels and expression patterns [12].
18 protein spots (Fig. 1) were unambiguously identified by
MALDI-MS based on PMF and amino acid sequence tags
derived from mass spectrometric fragment ion analysis and
results are listed in detail in Table 2. For spots 3 and 18 two
highly sequence homologous protein variants were identified
showing nearly identical theoretical pI- andMr-values. In both
cases, one unique peptide was assigned to the most probable
variant; therefore either only this protein variant or a mixture
of both protein variants is contained in the spot. For two
proteins multiple spots with similar expression patterns were
identified located at similar Mr, but at different pI-positions
(Fig. 1, spots 4/5 and spots 10/11). This is likely due to different
post-translational modifications, which were not further
investigated within the present study. The remaining eight
differentially expressed spots could not be successfully
identified because database searching with PMFs and se-
quence tag data did not yield significant results. This can be
explained either by insufficient amount of protein and/or
incomplete peptide cleavage/extraction (hydrophobic interac-
tions with gel matrix) combined with non-optimal fragmen-
tation behavior.
Identified proteins were grouped on the basis of their major
cellular functionaccording to thePANTHERclassification system
[25], gene ontology (GO) [26] and UniProtKB databases [27]
(Table 2). In line with the role of Tyk2 in autocrine/paracrine
IFNα/β signaling, we identified four proteins known as IFNα/β-
regulated proteins: T-cell specific GTPase (TGTP), proteasome
activator complex subunit 1 (PSME1), IFN-induced protein withtetratricopeptide repeats3 (IFIT3) and IFN-activableprotein205-B
(IFI5B). All of them showed decreased protein expression in the
absence of Tyk2 in the basal state and/or after poly(I:C)
stimulation. Remarkably, themajority of differentially expressed
protein spots were identified as metabolic enzymes and all
showed an increased expression by 1.40- to 2.29-fold in the
absenceofTyk2afterpoly(I:C) treatment.All of themare involved
in cellular lipid or carbohydrate metabolic processes, or both
(Fig. 2). Long-chain-fatty-acid-CoA ligase 4 (ACSL4), peroxisomal
multifunctional enzyme type 2 (DHB4) and peroxisomal 3-
ketoacyl-CoA thiolase A or B (THIKA/B) are enzymes of the fatty
acid degradation pathway (β-oxidation) [27,28]. DHB4 and
THIKA/B are exclusively allocated to peroxisomal and ACSL4 to
mitochondrial and peroxisomal subcellular compartments. In
addition, catalase (CATA) degrades H2O2, which is produced as a
result of peroxisomal β-oxidation [29]. Regarding carbohydrate
metabolism, we found triosephosphate isomerase (TIM), fruc-
tose-bisphosphate aldolase A (ALDOA) and α-enolase (ENOA),
which are all involved in the glycolytic/gluconeogenesis path-
ways. Furthermore, ATP-citrate lyase (ACLY), which is required
for acetyl-CoA formation, and aconitate hydratase (ACON),
which is a part of the tricarboxylic acid cycle (TCA, citrate
cycle), were differentially regulated between WT and Tyk2−/−
cells. TIM and ACLY are enzymes linking carbohydrate and lipid
metabolic processes. TIM participates in the production of
glycerol, a precursor for the synthesis of triacylglycerol (TAG),
whereas ACLY is involved in the glucose-dependent lipogenesis
[27,28]. In summary, the presented results show a substantial
impact of Tyk2 on the expression of proteins mainly involved in
fatty acid degradation and glycolysis.
From the proteins identified, one IFNα/β-regulated protein
and three enzymes involved in carbohydrate and/or lipid
metabolic pathways were selected for more detailed analysis.
3.3. Transcriptional up-regulation of TGTP in response to
poly(I:C) is reduced in the absence of Tyk2
TGTP is a member of the 47 kDa GTPase family [30] and was
discovered based on its transcriptional induction by IFNγ in
Table 2 – Summary of differentially expressed protein spots in Tyk2-deficient macrophages +/− poly(I:C).
Peptide mass fingerprint Sequence tag determination
Spot
#
Protein name/
function
SWISSPROT
accession #
WT Tyk2−/− WT+poly(I:C)
treatment
Tyk2−/−+
poly(I:C)
treatment
Average
ratio
Tyk2−/−
vs. WT+
poly(I:C)
treatment
p(gt)a p
(gt×tr)b
MWt
(kDa)
theor.
p/
theor.
Probability
based
MOWSE
score
Sequ.
cov. %
Matched/
unmatched
peptides
Probability
based
MOWSE
score
Precursor
Ion(s)
m/z
(observed)
and charge
state
Peptide
sequence(s)
Metabolism
1 Long-chain-fatty-acid-CoA
ligase 4 (ACSL4)
Q9QUJ7 1 1.28 0.76 1.45 1.90 ns c 5.62E-
05
79.22 8.51 97 18 9/7 75 1002.20 + FEIPIKVR
1557.62 + TAEDYCVDENGQR
1628.89 + YNFPLVTLYATLGR
2 Peroxisomal multifunctional
enzyme type 2 (DHB4)
P51660 1 1.07 0.62 0.90 1.44 ns 7.28E-
03
79.95 8.76 218 26 16/2 58 1283.52 + IDVVVNNAGILR
1323.47 + DATSLNQAALYR
1529.67 + HVLQQFADNDVSR
3 3-ketoacyl-CoA thiolase A,
peroxisomal (THIKA)d
Q921H8 1 1.07 0.68 1.56 2.29 ns 8.28E-
04
43.95 8.74 157 36 11/7 158 1569.73 + FPQASASDVVVVHGR
2043.37 + IAQFLSGIPETVP
LSTVNR
3-ketoacyl-CoA thiolase B,
peroxisomal (THIKB)d
Q8VCH0 43.99 8.82 67 20 6/12 68 2043.37 + IAQFLSGIPETVP
LSTVNR
4 Catalase (CATA) P24270 1 1.40 0.99 1.44 1.45 9.05E-
03
3.58E-
02
59.77 7.72 70 13 5/2 53 1277.44 + LAQEDPDYGLR
1392.53 + NFTDVHPDYGAR
5 Catalase (CATA) P24270 1 1.42 0.58 1.22 2.12 1.34E-
02
3.97E-
03
59.77 7.72 139 22 10/2 77 1277.41 + LAQEDPDYGLR
1392.46 + NFTDVHPDYGAR
6 ATP-citrate synthase (ACLY) Q91V92 1 1.25 0.58 0.91 1.57 2.03E-
02
7.06E-
04
119.73 7.13 185 18 15/2 42 875.01 + EAGVFVPR
1568.84 + TIAIIAEGIPEALTR
7 Triosephosphate isomerase
(TIM,TPIS)
P17751 1 1.21 0.73 1.13 1.56 8.26E-
04
7.95E-
04
26.71 6.90 244 65 14/4 112 1248.34 + SNVNDGVAQSTR
1540.71 + DLGATWVVLGHSER
8 Fructose-bisphosphate
aldolase A (ALDOA)
P05064 1 1.21 0.83 1.47 1.76 5.26E-
03
5.89E-
04
39.36 8.30 120 29 7/1 176 2108.36 + IGEHTPSALAI
MENANVLAR
2259.38 + YTPSGQSGAAASE
SLFISNHAY
9 α-enolase (ENOA) P17182 1 1.33 0.86 1.20 1.40 2.72E-
02
1.63E-
02
47.14 6.37 120 19 8/1 63 704.80 + GVPLYR
1440.60 + YITPDQLADLYK
10 Aconitate hydratase,
mitochondrial (ACON)
Q99KI0 1 1.11 0.48 0.78 1.63 4.11E-
02
3.21E-
03
85.46 8.08 86 11 8/5 84 1464.62 + SQFTITPGSEQIR
1602.73 + NAVTQEFGP
VPDTAR
11 Aconitate hydratase,
mitochondrial (ACON)
Q99KI0 1 1.23 0.82 1.19 1.46 5.40E-
04
1.08E-
03
85.46 8.08 311 33 23/4 136 1464.64 + SQFTITPGSEQIR
1602.77 + NAVTQEFGP
VPDTAR
(continued on next page)
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Table 2 (continued)
Peptide mass fingerprint Sequence tag determination
Spot
#
Protein name/
function
SWISSPROT
accession #
WT Tyk2−/− WT+poly(I:C)
treatment
Tyk2−/−+
poly(I:C)
treatment
Average
ratio
Tyk2−/−
vs. WT+
poly(I:C)
treatment
p(gt)a p
(gt×tr)b
MWt
(kDa)
theor.
p/
theor.
Probability
based
MOWSE
score
Sequ.
cov. %
Matched/
unmatched
peptides
Probability
based
MOWSE
score
Precursor
Ion(s)
m/z
(observed)
and charge
state
Peptide
sequence(s)
Immune response
12 T cell-specific GTPase (TGTP) NP_035709e 1 1.09 8.53 4.39 0.51 ns 3.15E-
03
47.15 5.49 310 54 20/0 152 1679.87 + FGEYDFFIIISATR
1867.08 + DIESAPLHIAVT
GETGAGK
13 Proteasome activator
complex subunit 1 (PSME1)
P97371 1 0.70 1.53 1.37 0.89 1.07E-
04
ns 28.67 5.73 270 71 18/3 146 1396.63 + NAYAVLYDIILK
1873.03 + QLVHELDEAEY
QEIR
14 Interferon-induced protein
with tetratricopeptide
repeats 3 (IFIT3)
Q64345 1 0.66 7.15 4.78 0.67 3.61E-
03
1.36E-
03
47.93 5.51 241 52 22/7 237 1741.90 + STVNNSPLYSLV
MCR
1891.12 + KSEDLAALEC
LLQFPR
15 Interferon-activable
protein 205-B (IFI5B)
Q08619 1 0.26 2.76 3.15 1.14 3.61E-
06
2.80E-
01
47.59 8.38 58 11 6/5 141 1361.48 + QMIEVPNCITR
1772.04 + GILEINETSSV
LEAAPK
Others
16 Immune-responsive
protein 1 (IRG-1)
P54987 1 1.16 34.73 58.59 1.69 ns 4.05E-
03
54.01 7.09 71 13 5/2 90 1169.28 + ALFPADHIER
1579.68 + LSSMSSFDHTTLPR
17 UMP-CMP kinase 2,
mitochondrial (CMPK2)
(Thymidylate kinase
LPS-inducible member - TYKi)
Q3U5Q7 1 0.84 13.96 8.03 0.58 ns 1.26E-
03
50.03 6.89 192 31 13/3 142 1102.32 + VLELIQSSGR
1622.73 + AVLEECTSFIPEAR
18 EH domain-containing
protein 1 (EHD1)d
Q9WVK4 1 1.34 2.03 3.18 1.57 ns 5.00E-
04
60.60 v6.35 180 32 15/3 140 1237.38 + LNAFGNAFLNR
1675.80 + LLDTVDDMLAN
DIAR
2015.27 + VYIGSFWSH
PLLIPDNR
EH domain-containing
protein 3 (EHD3)d
Q9QXY6 60.87 6.03 69 16 7/11 77 1237.38 + LNAFGNAFLNR
2015.27 + VYIGSFWS
HPLLIPDNR
a p-values for the differences between genotypes (gt) under basal conditions.
b p-values for the differences between genotypes in response to poly(I:C) treatment (gt×tr).
c Not significant (p-value>0.05).
d Proteins with high sequence homology.
e Accession # from NCBI nr database.
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glucose
glucose
pyruvat
lactate
glycerol triacylglycerol
fatty acids
acetyl-CoA
cholesterol
OXPHOS
acetyl-CoA
ALDOA
ENOA
ACLYACON
ACSL4
CATA
lactate
citrate
malate
OAAOAA
TCA
cycle
isoprenoids
glycolysis
fatty acid
degradation
TIM
pyruvat
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THIKA/B
CO2
Fig. 2 – Overview of identified enzymeswithin themetabolic pathways. Scheme showing the identified differentially regulated
metabolic enzymes (depicted in blue), metabolic pathways and the connection to specific metabolites (triacylglycerol,
cholesterol and lactate). ACLY, ATP-citrate lyase; ACON, aconitate hydratase; ACSL4, long-chain-fatty-acid-CoA ligase 4;
ALDOA, fructose-bisphosphate aldolase A; CATA, catalase; DHB4, peroxisomal multifunctional enzyme type 2; ENOA,
α-enolase; OAA, oxalacetate; OXPHOS, oxidative phosphorylation; TCA cycle, tricarboxylic acid cycle; THIKA/B, peroxisomal
3-ketoacyl-CoA thiolase A or B; TIM, triosephosphate isomerase.
2873J O U R N A L O F P R O T E O M I C S 7 4 ( 2 0 1 1 ) 2 8 6 6 – 2 8 8 0macrophages and T-cells [31]. TGTP is also efficiently induced
by transfected poly(I:C) in fibroblast cell lines in an IFNα/β-
dependent manner [32]. TGTP possesses specific antiviral
activity, is induced upon MCMV infection [33] and is implicat-
ed in cell survival after infection with vesicular stomatitis
virus, but not herpes simplex virus [32]. Confirming our data
from the 2D-DIGE analysis (Table 2, spot 12 and Fig. 3A), we
found a strong and partially Tyk2-dependent up-regulation of
TGTP byWestern blot analysis (Fig. 3B). As expected, induction
of TGTP occurred at the transcriptional level (Fig. 3C) and was
clearly reduced, but not abolished, in Tyk2-deficient cells. In
contrast to the 2D-DIGE data (Fig. 3A), TGTP mRNA expression
(Fig. 3C) and TGTP protein expression as determined by
Western blot analysis (Fig. 3B, middle panel) were already
significantly reduced in untreated Tyk2−/− cells. Despite this
discrepancy in the basal state, these data further confirm the
requirement of Tyk2 for efficient autocrine/paracrine IFNα/β
responses and extend our previous findings to additional
IFNα/β-stimulated proteins.
3.4. Tyk2 is required for transcriptional regulation of
ACSL4 and TIM
ACSL4 belongs to the large family of long-chain acyl-CoA
synthetases (ACSLs) [34], which are essential for de novo lipid
synthesis, fatty acid degradation and phospholipid remodeling
of membranes. Membrane-bound ACSL proteins catalyze ATP-
dependent activation of hydrophobic long-chain fatty acids to
hydrophilic acyl-CoA, whereby ACSL4 specifically prefersarachidonate as substrate [35]. According to the presented 2D-
DIGE data, ACSL4 was down-regulated by poly(I:C) treatment to
0.76-fold in WT cells (Table 2, spot 1 and Fig. 4A). In the
absence of Tyk2, ACSL4 was slightly but not significantly
enhanced in untreated cells and, importantly, ACSL4 was not
down-regulated after poly(I:C) treatment (Fig. 4A). The mean
difference betweenWT and Tyk2−/− cells in ACSL4 levels after
poly(I:C) treatment was 1.9-fold (Table 2, spot 1). We next
analyzed whether ACSL4 was also regulated at the transcrip-
tional level. As shown in Fig. 4B, ACSL4 mRNA was down-
regulated after 4 h of poly(I:C) treatment and reached levels
of 0.5-fold at 18 h after treatment in WT cells. Although
ACSL4 mRNA was also slightly down-regulated in Tyk2-
deficient cells, mRNA levels were significantly higher than in
WT cells from 8 h after poly(I:C) treatment onwards.
TIM, also knownas TPI or TPIS, catalyzes the isomerization of
dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde-3-
phosphate (GADP). DHAP and GADP occur as intermediates in
the glycolysis/gluconeogenesis pathways and DHAP can also be
metabolized to glycerol, a precursor for the synthesis of TAG [36].
As determined by 2D-DIGE, the TIM spot intensity patterns were
very similar to those of ACSL4. TIM was modestly down-
regulated by poly(I:C) treatment in WT cells and absence of
Tyk2 resulted in significantly higher TIM levels both before and
after poly(I:C) treatment (Table 2, spot 7 and Fig. 4C). The
differenceswere again verymodest and higher after stimulation
(Tyk2−/− vs. WT ratios in the basal and treated state of 1.21-fold
and 1.56-fold, respectively). TIM mRNA was transiently down-
regulated in WT and, to a lesser extent, in Tyk2−/−macrophages
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TGTP mRNA expression (RT-qPCR)
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Fig. 3 – Effect of Tyk2 deficiency on TGTP expression levels. Macrophages were treated with poly(I:C) for the times indicated or
left untreated (untr., 0 h) and whole cell lysates were analyzed by (A) 2D-DIGE and (B) Western blotting or (C) total RNA was
isolated and mRNA expression determined by RT-qPCR. (A) Expression levels as determined by 2D-DIGE (untr. and 18 h poly
(I:C)) are given as fold ratios relative to untreatedWT cells. Mean values±SD of three biological replicates are depicted. (B) 10 μg
protein per lane was separated by SDS-PAGE (10%T) and probed with an anti-TGTP antibody (short and long exposures are
depicted). ERK p42/p44 was used as loading control. Data are representatives of three independent experiments. (C) Mean
values of TGTP mRNA expression±SE from three independent experiments are depicted. Expression levels are shown relative
to untreated WT cells, Ube2d2 was used for normalization. Significance levels of genotype-specific differences for each time
point are indicated with * p≤0.05 and ** p≤0.01. Significance levels not indicated in the figures are for WT untreated vs. all
treatment time points p≤0.01, Tyk2−/− untreated vs. all treatment time points p≤0.01.
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compared to WT cells at 8 h and 18 h after poly(I:C) treatment,
however, a trend for enhanced expression was also seen at 4 h
and 12 h (p≤0.1). As might be expected based on these relatively
small changes in expression levels, we could not detect
consistent differences in protein levels of ACSL4 and TIM using
Western blot analysis (data not shown). Taken together, both
ACSL4andTIMare clearly, butmodestly, transcriptionallydown-
regulated in response to poly(I:C) treatment and this is at least
partially mediated by Tyk2-dependent mechanisms.
3.5. Tyk2 is involved in the post-translational regulation
of ACLY
ACLY is a cytosolic enzyme that catalyzes the conversion of
mitochondria-derived citrate to oxalacetate and acetyl-CoA.
Acetyl-CoA is further utilized for the synthesis of fatty acids,
cholesterol and isoprenoids. Oxalacetate is reduced to malate,
which can return to the mitochondria and complete the
substrate cycle [28]. ACLY can also positively regulate glycol-ysis, presumably via the removal of citrate, which acts as a
glycolytic inhibitor [37]. ACLY protein spot levels as deter-
mined by 2D-DIGE were modestly reduced to 0.58-fold by poly
(I:C) treatment in WT cells and 1.57-fold up-regulated in
Tyk2−/− as compared to WT cells after poly(I:C) treatment
(Table 2, spot 6 and Fig. 5A). Similar to TIM, differences in
ACLY spot intensities were already evident in untreated cells.
Interestingly, we found only minor differences between WT
and Tyk2−/− cells at themRNA level (Fig. 5B). ACLYmRNAwas
reduced about 4-fold in bothWT and Tyk2−/− cells after poly(I:
C) treatment. Significantly enhanced ACLYmRNA expression
was only detectable at 12 h after poly(I:C) treatment in Tyk2−/−
cells, butmRNA levelswere again similar to those inWT cells at
the 18 h time point. Surprisingly, despite the clear down-
regulation of ACLYmRNA,ACLYprotein levelswere unchanged
in both WT and Tyk2−/− cells in response to poly(I:C) treatment
(Fig. 5C). In addition to the full-length ACLY protein (around
125 kDa), we also found an immunoreactive band at a lower Mr.
The latter likely corresponds to one of the previously reported
proteolytic cleavage products of ACLYwith a reported Mr of 50–
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Fig. 4 – Effect of Tyk2 deficiency on ACSL4 and TIM expression levels. Macrophages were treated with poly(I:C) for the times
indicated or left untreated (untr., 0 h) and (A, C) whole cell lysateswere analyzed by 2D-DIGE or (B, D) total RNAwas isolated and
mRNA expression determined by RT-qPCR. Expression levels are given as described in the legend to (A, C) Fig. 3A and
(B, D) Fig. 3C. Significance levels of genotype-specific differences for each time point are indicated with * p≤0.05 and ** p≤0.01.
Significance levels not indicated in the figures are for (B) WT untreated vs. all treatment time points p≤0.01, Tyk2−/− untreated
vs. 4 h treatment p≤0.05 and for (D) WT untreated vs. 4 h poly(I:C) p≤0.01 and 8 h treatment p≤0.05, Tyk2-/− untreated vs. 4 h
treatment p≤0.05.
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rat liver homogenates [38,39] and in glioblastoma cell lines [37]
and, importantly, retains its full enzymatic activity [39]. A
50 kDa ACLY fragment was also identified as a phospho-
acceptor protein in rat liver [40]. Murine ACLY can be
phosphorylated at serine 455 (S455) and tyrosine 672 (Y672)
and multiple additional phosphorylation sites are predicted by
similarity to human or rat ACLY, e.g. threonine 447 (T447) and
S451 [27,41]. In order to test whether poly(I:C) treatment and/
or Tyk2 deficiency affects ACLY phosphorylation, we per-
formed Western blot analysis with the commercially avail-
able phospho-ACLY-specific antibodies. As shown in Fig. 5D,
phospho(P)-T447/S451 was detectable in untreated cells,
unchanged by poly(I:C) treatment and similar between WT
and Tyk2−/− cells. Notably, P-T447/S451-ACLY was only
detected at the Mr corresponding to full-length ACLY. In
contrast, P-S455-ACLY was strongly induced upon poly(I:C)
treatment (Fig. 5E). P-S455-ACLY was mainly found at the
lower Mr band, indicating that cleaved ACLY is preferentially
phosphorylated or, alternatively, P-S455 targets full-length
ACLY for proteolysis. As the total amount of the ACLY
fragment did not increase upon stimulation (Fig. 5C), theformer possibility is more likely. It is possible that proteolytic
cleavage occurs during the protein isolation procedure, as
activated macrophages express particularly high levels of
proteases and ACLY is quite unstable [40]. However, we
observed similar levels of the proteolytic product even under
more stringent lysis conditions, i.e. using RIPA buffer (data
not shown). Importantly, the poly(I:C)-mediated increase of
P-S455-ACLY was clearly reduced in Tyk2−/− cells (Fig. 5E).
Phosphorylation of human ACLY at S455 has been shown to
increase ACLY enzymatic activity around 6-fold, whereas
phosphorylation on T447/S541 had no detectable effect [42].
In relation to our 2D-DIGE data, we assume that the poly(I:C)-
induced down-regulation of the 125 kDa ACLY spot identified
with MS is a result of post-translational modification(s), i.e.
shifts in pI caused by phosphorylation and/or changes in Mr
by proteolytic cleavage. As indicated by the mRNA data, it is
also possible that total ACLY protein levels are decreased in
response to poly(I:C), but as we did not find any differences
using semi-quantitative Western blots these changes must
be rather modest. Taken together, our data suggest that the
major effect of poly(I:C) treatment on ACLY is the induced
S455 phosphorylation and the likely resulting increase of
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Fig. 5 – Effect of Tyk2 deficiency on ACLY expression levels. Macrophages were treated with poly(I:C) for the times indicated or
left untreated (untr., 0 h) and whole cell lysates were analyzed by (A) 2D-DIGE, (C–E) Western blotting or (B) total RNA was
isolated andmRNA expression determined by RT-qPCR. Expression levels are given as described in the legend to (A) Fig. 3A and
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(D) anti-phospho-T447/S451-ACLY and (E) anti-phospho-S455-ACLY antibody. (C–E) ERK p85 was used as loading control. Data
are representatives of three independent experiments. (A, B) Significance levels of genotype-specific differences for each
treatment are indicated with * p≤0.05 and ** p≤0.01. Significance levels not indicated in the figures are for bothWT and Tyk2−/−
cells untreated vs. all treatment time points p≤0.01. (C–E) W, WT; T, Tyk2−/−.
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expression, but was required for maximal poly(I:C)-mediated
ACLY S455 phosphorylation.
3.6. Tyk2 is required for the up-regulation of cellular total
cholesterol and extracellular lactate in macrophages
Wenext decided tomore directly test the influence of poly(I:C)
treatment and the consequences of Tyk2 deficiency on cellular
metabolism. To this end, we assessed the impact of Tyk2 on
the amounts of cellular total cholesterol (TC), TAG and
extracellular lactate. As most of the effects of Tyk2 in
macrophages were thus far attributable to its role in type I
IFN signaling, we included macrophages derived from IFNα/β
receptor 1-deficient (IFNAR1−/−) mice in these analyses and,
additionally, treated cells with recombinant IFNβ. The cellular
TC concentration was slightly (1.16-fold) but significantly
increased in WT cells after poly(I:C) treatment (Fig. 6A). TC
levels of both Tyk2−/− and IFNAR1−/− macrophages were
similar to those of WT cells in the untreated state, but showed
no increase in response to poly(I:C). TC levels after IFNβ
treatment remained unchanged in all three genotypes
(Fig. 6A). Thus, functional IFN signaling is required but not
sufficient for the up-regulation of cellular TC. A similar but not
identical picture appeared for the TAG concentrations (Fig. 6B).In WT cells, poly(I:C) treatment resulted in a modest but
consistent increase in cellular TAG levels (Fig. 6B). Again,
IFNAR1 was required for this effect, but treatment with IFNβ
alone did not cause any changes in TAG levels. TAG levels in
Tyk2−/− cells were comparable to WT cells before and after
poly(I:C) treatment (Fig. 6B). The strongest poly(I:C)-mediated
changeswere observed for extracellular lactate (Fig. 6C). InWT
cells, 3.43-fold increased lactate levels were found after 18 h of
poly(I:C) treatment. Neither Tyk2 nor IFNAR1 deficiency
resulted in changes of extracellular lactate levels in untreated
cells, but up-regulation by poly(I:C) was clearly reduced in both
genotypes. WT cells treated with exogenous IFNβ showed a
modest up-regulation of extracellular lactate and this was, as
expected, not observed in cells lacking IFNAR1. In contrast to
TC and TAG, IFNβ alone is sufficient to induce a change in
lactate release, nevertheless other poly(I:C)-induced factors
contribute to the effect. The poly(I:C)- and the IFNβ-mediated
increase in lactate release were partially or completely
dependent on the presence of Tyk2.4. Discussion
Tyk2 is mainly associated with its protective role during
microbial infections. In macrophages, absence of Tyk2 results
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Fig. 6 – Effects of Tyk2 and IFNAR1 deficiency on metabolite
concentrations. Macrophages were cultivated in the absence
(untreated) or presence of poly(I:C) or IFNβ for 18 h.
Intracellular (A) TC and (B) TAG and (C) extracellular lactate
were measured enzymatically and normalized to cellular
total protein content. Results are mean values±SE of the
following number of independent experiments: TC, n=7;
TAG, n=3; lactate, n=4. Significance levels of
genotype-specific differences for each treatment are
indicated with * p≤0.05 and ** p≤0.01. Significance levels not
indicated in the figures: TC, WT (untreated) vs. WT (poly(I:C))
p≤0.01; TAG, WT (untreated) vs. WT (poly(I:C)) p≤0.05;
lactate, WT (untreated) vs. WT (poly(I:C)) p≤0.01, WT
(untreated) vs. WT (IFNβ) p≤0.05.
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and increased virus sensitivity [5,12,24]. In the present study,
we show that besides the expected effects on immune
response proteins, Tyk2 is involved in the regulation of
carbohydrate and lipid metabolism in macrophages exposed
to poly(I:C). By means of 2D-DIGE and MS we find protein spot
expression levels of 9 distinct enzymes known to be involved
in carbohydrate and/or fatty acid metabolism up-regulated in
the absence of Tyk2. We further analyzed mRNA expressionpatterns for TIM, ACSL4 and ACLY and found transcriptional
and post-transcriptional effects of Tyk2. Importantly, we also
correlate our findings to metabolite abundance.
TIM catalyzes the equilibrium of triosephosphates in the
gluconeogenesis/glycolysis pathway, which is also connected to
fatty acid biosynthesis [36]. We report here that TIM is
transcriptionally down-regulated in a Tyk2-dependent manner
after poly(I:C) treatment. However, the difference between WT
and Tyk2−/− cells was less than 2-fold at the mRNA and protein
spot level and could not be detected by Western blot analysis.
Similarly, ACSL4, which is involved in fatty acid degradation,
showed modest and Tyk2-dependent transcriptional down-
regulation by poly(I:C) treatment. This is in accordance with a
previous transcriptional study inmacrophages treated with LPS,
in which genes annotated to lipid and cholesterol metabolism
were, as a group, significantly regulated in a Tyk2-dependent
manner, but showed a very modest amplitude of regulation at
the single gene level [43]. Small changes in multiple enzyme
transcript levels that impact onoverall cellularmetabolic activity
have been reported just recently in the context of sterol
biosynthesis and viral infection [44]. ACLY is best known for its
involvement in glucose-mediated lipogenesis [28]. From a cell-
signaling perspective the recent finding that ACLY is also the
major source of acetyl-CoA required for histone acetylation and
selective gene expression in response to growth factor stimula-
tion and during adipocyte differentiation is of particular interest
[45]. We found that ACLY mRNA is down-regulated by poly(I:C)
treatment in WT and Tyk2−/− macrophages. Phosphorylation of
ACLY at S455 is strongly induced by poly(I:C) treatment and is
clearly reduced in the absence of Tyk2. S455 phosphorylation of
ACLY substantially enhances its enzymatic activity in vitro [42],
arguing for a poly(I:C)-mediated increase in ACLY activity,
despite the modest down-regulation of its mRNA level. Nutri-
ents, insulin and interleukin-3 were shown to induce phosphor-
ylationofS455-ACLYand increasedP-S455-ACLYwas reported in
tumor cell lines and tissues [37,46,47]. More related to our study,
induction of P-S455-ACLY has recently been demonstrated in
human fibroblasts infectedwith CMV [48]. Protein kinase B (PKB/
Akt) and cAMP-dependent protein kinase (PKA) can act as ACLY
S455 kinases in vitro and, PKB/Akt has been linked to ACLY S455
phosphorylation in lung adenocarcinoma cell lines and in
response to insulin in adipocytes [42,46,49–51]. As type I IFNs
canactivate PKB/Akt [52] itmaybe speculated that reducedACLY
phosphorylation in the absence of Tyk2 is due to reduced
autocrine/paracrine IFNα/β-mediated PKB/Akt activation.
Interconnections between infection/inflammation and
lipid metabolism are becoming increasingly apparent
[53–55], but underlying molecular mechanisms are only just
beginning to emerge. Because of their anticipated role in
atherosclerosis [56], most studies in macrophages focus on
their differentiation into lipid-loaden foam cells in the
presence of modified low-density lipoprotein. Nevertheless,
an increase in intracellular TAG even in the absence of
exogenous lipid has been previously reported in RAW264.7
macrophage cells treated with LPS [57,58]. We show a slight
but significant increase in TAG levels upon poly(I:C) treatment
in WT but not in IFNAR1−/− cells. In contrast, no effect on TAG
levels upon poly(I:C) treatment was reported in a previous
study [58]. One possible reason for this discrepancy is the
difference in the type of macrophages used, i.e. primary
2878 J O U R N A L O F P R O T E O M I C S 7 4 ( 2 0 1 1 ) 2 8 6 6 – 2 8 8 0macrophages versus a cell line. As we find enzymes involved
in fatty acid degradation and synthesis down-regulated by
poly(I:C), it is also possible that the fatty acid composition is
altered during macrophage activation. Similar to TAG, we
found a slight increase in TC concentrations after poly(I:C)
treatment. This was dependent on the presence of both Tyk2
and IFNAR1. Liver X receptors (LXRs) are nuclear receptors
crucial for the regulation of cholesterol homeostasis and
involved in the crosstalk between lipid metabolism and TLR
signaling [59,60]. Stimulation with TLR3 or TLR4 ligands blocks
macrophage cholesterol efflux by blocking expression of LXR
target genes, e.g. the cholesterol effluxmediators ATP-binding
cassette sub-family A member 1 (ABCA1) and sub-family G
member 1 (ABCG1) [59]. Intracellular cholesterol levels were,
however, not determined in this study. The inhibition of LXR
target gene expression occurred independent of type I IFN [59],
indicating that the IFNAR1-dependent, poly(I:C)-mediated
increase in intracellular cholesterol reported herein is caused
by a different mechanism. In contrast to our data, MCMV
infection and IFNβ treatment resulted in 2-fold decreased
cellular free cholesterol levels [44]. This difference might be
explained by differences between MCMV- and poly(I:C)-
induced cellular responses.
In most cells, including macrophages, glycolysis serves to
convert glucose to pyruvate and then generate ATP by
oxidative phosphorylation (OXPHOS). At low oxygen level
pyruvate is converted to lactate (anaerobic glycolysis) to
produce ATP, however with less efficiency [61]. We show
that extracellular lactate levels strongly increase after poly(I:C)
treatment, indicating an increase in glycolytic rates. In line
with this, a strong increase in extracellular lactate was
observed in macrophages stimulated with LPS [62,63]. More
recently, a shift from OXPHOS to anaerobic glycolysis was
reported in dendritic cells activated with LPS and, interest-
ingly, this was dependent on the presence of PKB/Akt [64]. We
propose a similar shift in response to poly(I:C) and demon-
strate a strong but not absolute requirement for IFNAR1 and
Tyk2. Of note, studies in the 1960s already suggested effects of
IFNs on OXPHOS in the context of viral infections [65,66]. Our
data support this hypothesis and provide evidence that Tyk2
facilitates the transition fromOXPHOS to anaerobic glycolysis.
Given the importance of lipid and glucose metabolism for
the innate and adaptive immune system [53], it appears likely
that the defects in metabolic reprogramming upon immune
stimulation in Tyk2−/− macrophages reported herein contrib-
ute to immunological phenotypes described in Tyk2−/− mice.
In particular the failure to efficiently switch from OXPHOS to
anaerobe glycolysis might impair macrophage activation and
result in increased sensitivity to death by nutrient limitation.
This could broadly inhibit inflammatory processes and
contribute to the resistance of Tyk2−/− mice to inflammation-
induced pathologies. Control of glucose metabolism is, for
example, considered as promising therapeutic approach in
sepsis, although it emerged more difficult than initially
anticipated [67]. Against this background it seems interesting
to determine whether Tyk2−/− mice show reduced hypergly-
cemia during LPS-induced shock. Our results also raise the
question whether the metabolic phenotype extends to other
cell types. This is particularly interesting in lymphocytes, as
they have a high glucose-dependent energy demand duringclonal expansion upon antigen encounter [53], and Tyk2−/−
pro-B cells exhibit defects in homeostatic and IFNβ-induced
mitochondrial respiration [68].5. Concluding remarks
The presented data show that the absence of Tyk2 results in
significant changes on cellular protein abundance in macro-
phages in the basal state and upon poly(I:C) treatment, which
is in line with our recently published study on LPS responses
[12]. We observed an explicit impact of Tyk2 on the abundance
of several lipid and carbohydrate metabolic enzymes. We
show that Tyk2-dependent regulations occur transcriptionally
and/or post-transcriptionally and correlate these data to
changes in metabolite levels. Our data emphasize the
importance of Tyk2 for the regulation of cellular immune
responses and provide new evidence for a novel function of
Tyk2 linking metabolic and innate immune networks.Authors contributions
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